Neurodegenerative disorders

Alzheimer’s drug removes amyloid but does not guarantee cognitive benefit

A widely-anticipated drug treatment for Alzheimer’s disease has shown promising results in clearing amyloid plaques from the brain in a phase 2 study – but questionable effects on cognitive outcomes. Trial results for the Biogen/Eisei BAN2401 molecule were presented at the Alzheimer’s Association International Conference in Chicago on 25 July showing that the anti-amyloid drug ...

Already a member?

Login to keep reading.

© 2022 the limbic